We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
-12.91%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$131B
AUM Growth
-$19.5B
Cap. Flow
+$2.76B
Cap. Flow %
2.11%
Top 10 Hldgs %
14.61%
Holding
3,199
New
67
Increased
1,772
Reduced
1,049
Closed
53

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$361M
2
CVS icon
CVS Health
CVS
+$180M
3
CI icon
Cigna
CI
+$158M
4
MSFT icon
Microsoft
MSFT
+$102M
5
AMZN icon
Amazon
AMZN
+$90M

Sector Composition

Rank Sector Weight
1 Technology 15.86%
2 Financials 13.99%
3 Healthcare 13.63%
4 Industrials 10.39%
5 Consumer Discretionary 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDLX icon
3051
Cardlytics
CDLX
$21.7M
$151K ﹤0.01%
1,387
EPE
3052
DELISTED
EP Energy Corporation
EPE
$151K ﹤0.01%
215,379
-4,332
-2% -$6.47K
CELH icon
3053
Celsius Holdings
CELH
$7.41B
$150K ﹤0.01%
129,000
TRAK icon
3054
ReposiTrak
TRAK
$155M
$150K ﹤0.01%
25,000
MBII
3055
DELISTED
Marrone Bio Innovations, Inc.
MBII
$150K ﹤0.01%
101,700
PFSW
3056
DELISTED
PFSweb, Inc.
PFSW
$148K ﹤0.01%
28,700
VRDN icon
3057
Viridian Therapeutics
VRDN
$2.11B
$146K ﹤0.01%
3,200
CBUS icon
3058
Cibus
CBUS
$147M
$145K ﹤0.01%
279
-1
-0.4% -$599
CBNK icon
3059
Capital Bancorp
CBNK
$600M
$143K ﹤0.01%
+12,520
New +$156K
OVID icon
3060
Ovid Therapeutics
OVID
$424M
$142K ﹤0.01%
58,471
-1,216
-2% -$5.55K
REPL icon
3061
Replimune Group
REPL
$904M
$142K ﹤0.01%
14,160
TPHS
3062
DELISTED
Trinity Place Holdings Inc.com
TPHS
$142K ﹤0.01%
32,544
TBIO
3063
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$140K ﹤0.01%
18,590
KOPN icon
3064
Kopin
KOPN
$652M
$138K ﹤0.01%
137,600
MLNT
3065
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$137K ﹤0.01%
34,350
-3,092
-8% -$39.5K
METC icon
3066
Ramaco Resources Class A
METC
$607M
$136K ﹤0.01%
28,306
-550
-2% -$3.37K
FENC icon
3067
Fennec Pharmaceuticals
FENC
$331M
$135K ﹤0.01%
21,100
DWSN icon
3068
Dawson Geophysical
DWSN
$145M
$134K ﹤0.01%
39,500
NL icon
3069
NLI Holdings
NL
$281M
$133K ﹤0.01%
37,688
-760
-2% -$3.71K
NBEV
3070
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$131K ﹤0.01%
+25,010
New +$131K
CWBR
3071
DELISTED
CohBar, Inc. Common Stock
CWBR
$130K ﹤0.01%
1,383
SNDX icon
3072
Syndax Pharmaceuticals
SNDX
$1.68B
$129K ﹤0.01%
28,882
+4,700
+19% +$25.8K
NEXT icon
3073
NextDecade
NEXT
$1.75B
$128K ﹤0.01%
23,688
-304
-1% -$1.53K
NWHM
3074
DELISTED
THE NEW HOME COMPANY INC.
NWHM
$125K ﹤0.01%
23,849
NATR icon
3075
Nature's Sunshine
NATR
$355M
$124K ﹤0.01%
15,180

Similar funds

Charles Schwab's Q4 2018 Portfolio in Review

As of Q4 2018, Charles Schwab held 3,199 positions worth $131B, down 13% from $150B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Trading was light in Q4 2018: portfolio turnover was 3.8%. Charles Schwab opened 67 new positions and exited 53, leaving the 3,199-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2018 buy was Linde: 2,286,208 shares worth $357M.
  • Charles Schwab added most to CVS Health in Q4 2018, an estimated $180M increase.
  • Charles Schwab's biggest Q4 2018 reduction was Qualcomm, cutting an estimated $42.7M.
  • Charles Schwab fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $301M.
  • Charles Schwab's ten largest holdings make up 15% of its $131B portfolio in Q4 2018.
  • Charles Schwab opened 67 new positions and closed 53 in Q4 2018.
  • Charles Schwab's portfolio value fell 13% quarter-over-quarter to $131B.

Based on Charles Schwab's 13F filing for Q4 2018, filed 14 Feb 2019.